nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00169	0.00169	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—RPE65—age related macular degeneration	0.00169	0.00169	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—ABCA4—age related macular degeneration	0.00167	0.00167	CbGpPWpGaD
Paliperidone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00166	0.00166	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—RHO—age related macular degeneration	0.00163	0.00163	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—ABCA4—age related macular degeneration	0.00161	0.00161	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—RHO—age related macular degeneration	0.00161	0.00161	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—ABCA4—age related macular degeneration	0.0016	0.0016	CbGpPWpGaD
Paliperidone—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00159	0.00159	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—RPE65—age related macular degeneration	0.00157	0.00157	CbGpPWpGaD
Paliperidone—HTR1D—GPCR ligand binding—CCL2—age related macular degeneration	0.00157	0.00157	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—ABCA4—age related macular degeneration	0.00156	0.00156	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR ligand binding—C3—age related macular degeneration	0.00155	0.00155	CbGpPWpGaD
Paliperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00154	0.00154	CbGpPWpGaD
Paliperidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00154	0.00154	CbGpPWpGaD
Paliperidone—HTR1B—GPCR ligand binding—CCL2—age related macular degeneration	0.00154	0.00154	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—ABCA4—age related macular degeneration	0.00154	0.00154	CbGpPWpGaD
Paliperidone—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00153	0.00153	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—SLC16A8—age related macular degeneration	0.00152	0.00152	CbGpPWpGaD
Paliperidone—DRD4—GPCR ligand binding—CCL2—age related macular degeneration	0.00151	0.00151	CbGpPWpGaD
Paliperidone—HTR1A—GPCR ligand binding—C3—age related macular degeneration	0.0015	0.0015	CbGpPWpGaD
Paliperidone—HTR2A—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00149	0.00149	CbGpPWpGaD
Paliperidone—HTR2C—GPCR ligand binding—C3—age related macular degeneration	0.00149	0.00149	CbGpPWpGaD
Paliperidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00149	0.00149	CbGpPWpGaD
Paliperidone—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00146	0.00146	CbGpPWpGaD
Paliperidone—ADRA2B—Hemostasis—CD36—age related macular degeneration	0.00146	0.00146	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—RHO—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR ligand binding—C3—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR ligand binding—C3—age related macular degeneration	0.00143	0.00143	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—ABCA4—age related macular degeneration	0.00142	0.00142	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—RHO—age related macular degeneration	0.0014	0.0014	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—NMNAT1—age related macular degeneration	0.0014	0.0014	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—RHO—age related macular degeneration	0.0014	0.0014	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—ABCA4—age related macular degeneration	0.00139	0.00139	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—ABCA4—age related macular degeneration	0.00139	0.00139	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—SLC16A8—age related macular degeneration	0.00139	0.00139	CbGpPWpGaD
Paliperidone—ADRA2C—Hemostasis—CD36—age related macular degeneration	0.00137	0.00137	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—ABCA4—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Paliperidone—DRD1—GPCR ligand binding—CCL2—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—RHO—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Paliperidone—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Paliperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Paliperidone—DRD3—GPCR ligand binding—CCL2—age related macular degeneration	0.00134	0.00134	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—RHO—age related macular degeneration	0.00134	0.00134	CbGpPWpGaD
Paliperidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00133	0.00133	CbGpPWpGaD
Paliperidone—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00133	0.00133	CbGpPWpGaD
Paliperidone—DRD2—GPCR ligand binding—C3—age related macular degeneration	0.00131	0.00131	CbGpPWpGaD
Paliperidone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.0013	0.0013	CbGpPWpGaD
Paliperidone—HTR2A—GPCR ligand binding—C3—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Paliperidone—HRH1—GPCR ligand binding—C3—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—ABCA4—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR ligand binding—C3—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Paliperidone—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—RHO—age related macular degeneration	0.00123	0.00123	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—ELOVL4—age related macular degeneration	0.00123	0.00123	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR ligand binding—CCL2—age related macular degeneration	0.00121	0.00121	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—RHO—age related macular degeneration	0.00121	0.00121	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—RHO—age related macular degeneration	0.00121	0.00121	CbGpPWpGaD
Paliperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00121	0.00121	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—RHO—age related macular degeneration	0.00119	0.00119	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR ligand binding—C3—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Paliperidone—HTR1A—GPCR ligand binding—CCL2—age related macular degeneration	0.00117	0.00117	CbGpPWpGaD
Paliperidone—HTR2C—GPCR ligand binding—CCL2—age related macular degeneration	0.00117	0.00117	CbGpPWpGaD
Paliperidone—HTR1D—GPCR downstream signaling—C3—age related macular degeneration	0.00113	0.00113	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR ligand binding—CCL2—age related macular degeneration	0.00113	0.00113	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR ligand binding—CCL2—age related macular degeneration	0.00112	0.00112	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—C3—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—CD36—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—RHO—age related macular degeneration	0.0011	0.0011	CbGpPWpGaD
Paliperidone—DRD4—GPCR downstream signaling—C3—age related macular degeneration	0.00109	0.00109	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TGFBR1—age related macular degeneration	0.00106	0.00106	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TGFBR1—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—C3—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Paliperidone—DRD2—GPCR ligand binding—CCL2—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Paliperidone—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TGFBR1—age related macular degeneration	0.00102	0.00102	CbGpPWpGaD
Paliperidone—HTR2A—GPCR ligand binding—CCL2—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Paliperidone—HRH1—GPCR ligand binding—CCL2—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—C3—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—C3—age related macular degeneration	0.000992	0.000992	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR ligand binding—CCL2—age related macular degeneration	0.000991	0.000991	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—SLC16A8—age related macular degeneration	0.000988	0.000988	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—C3—age related macular degeneration	0.000984	0.000984	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—C3—age related macular degeneration	0.00097	0.00097	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—SQSTM1—age related macular degeneration	0.000957	0.000957	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—LIPC—age related macular degeneration	0.000956	0.000956	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000937	0.000937	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—SQSTM1—age related macular degeneration	0.000923	0.000923	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—CETP—age related macular degeneration	0.000922	0.000922	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR ligand binding—CCL2—age related macular degeneration	0.00092	0.00092	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000917	0.000917	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000916	0.000916	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TGFBR1—age related macular degeneration	0.000904	0.000904	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—C3—age related macular degeneration	0.000893	0.000893	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—C3—age related macular degeneration	0.000881	0.000881	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—C3—age related macular degeneration	0.000876	0.000876	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—C3—age related macular degeneration	0.000846	0.000846	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—C3—age related macular degeneration	0.000841	0.000841	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—SQSTM1—age related macular degeneration	0.00083	0.00083	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—SQSTM1—age related macular degeneration	0.000819	0.000819	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—C3—age related macular degeneration	0.000818	0.000818	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000816	0.000816	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—CCL2—age related macular degeneration	0.000806	0.000806	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—C3—age related macular degeneration	0.000805	0.000805	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000801	0.000801	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—C3—age related macular degeneration	0.000796	0.000796	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—CCL2—age related macular degeneration	0.000789	0.000789	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000788	0.000788	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TGFBR1—age related macular degeneration	0.000784	0.000784	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—CCL2—age related macular degeneration	0.000776	0.000776	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—LIPC—age related macular degeneration	0.000776	0.000776	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—C3—age related macular degeneration	0.000768	0.000768	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—C3—age related macular degeneration	0.000764	0.000764	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TGFBR1—age related macular degeneration	0.000762	0.000762	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TGFBR1—age related macular degeneration	0.00075	0.00075	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—CETP—age related macular degeneration	0.000749	0.000749	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—C3—age related macular degeneration	0.000743	0.000743	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—C3—age related macular degeneration	0.000743	0.000743	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—SQSTM1—age related macular degeneration	0.00074	0.00074	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—C3—age related macular degeneration	0.000731	0.000731	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—C3—age related macular degeneration	0.000731	0.000731	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—C3—age related macular degeneration	0.000729	0.000729	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—C3—age related macular degeneration	0.000715	0.000715	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000714	0.000714	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—LIPC—age related macular degeneration	0.000711	0.000711	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—SQSTM1—age related macular degeneration	0.00071	0.00071	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—CCL2—age related macular degeneration	0.000699	0.000699	CbGpPWpGaD
Paliperidone—ADRA2B—Hemostasis—VEGFA—age related macular degeneration	0.000697	0.000697	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000692	0.000692	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—SQSTM1—age related macular degeneration	0.000691	0.000691	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—CCL2—age related macular degeneration	0.00069	0.00069	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—CETP—age related macular degeneration	0.000686	0.000686	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000681	0.000681	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—SQSTM1—age related macular degeneration	0.00068	0.00068	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000679	0.000679	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—C3—age related macular degeneration	0.000674	0.000674	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000666	0.000666	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—C3—age related macular degeneration	0.000665	0.000665	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—C3—age related macular degeneration	0.000663	0.000663	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—C3—age related macular degeneration	0.000662	0.000662	CbGpPWpGaD
Paliperidone—ADRA2C—Hemostasis—VEGFA—age related macular degeneration	0.000651	0.000651	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—C3—age related macular degeneration	0.00065	0.00065	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.000646	0.000646	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000627	0.000627	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—CCL2—age related macular degeneration	0.000623	0.000623	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000619	0.000619	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000617	0.000617	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000616	0.000616	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—C3—age related macular degeneration	0.000608	0.000608	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000604	0.000604	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—C3—age related macular degeneration	0.000604	0.000604	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—CCL2—age related macular degeneration	0.000601	0.000601	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—CCL2—age related macular degeneration	0.000598	0.000598	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—C3—age related macular degeneration	0.000596	0.000596	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—C3—age related macular degeneration	0.000586	0.000586	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—CCL2—age related macular degeneration	0.000582	0.000582	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—CCL2—age related macular degeneration	0.000572	0.000572	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—APOE—age related macular degeneration	0.000566	0.000566	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000561	0.000561	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—KDR—age related macular degeneration	0.000555	0.000555	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—APOE—age related macular degeneration	0.000554	0.000554	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—CD36—age related macular degeneration	0.000554	0.000554	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—APOE—age related macular degeneration	0.000546	0.000546	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—KDR—age related macular degeneration	0.000543	0.000543	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—KDR—age related macular degeneration	0.000535	0.000535	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—VEGFA—age related macular degeneration	0.000529	0.000529	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—CCL2—age related macular degeneration	0.000528	0.000528	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—C3—age related macular degeneration	0.000528	0.000528	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—C3—age related macular degeneration	0.000521	0.000521	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000519	0.000519	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—CCL2—age related macular degeneration	0.000518	0.000518	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—CCL2—age related macular degeneration	0.000508	0.000508	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—LIPC—age related macular degeneration	0.000506	0.000506	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—APOE—age related macular degeneration	0.000491	0.000491	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—APOE—age related macular degeneration	0.000489	0.000489	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—CETP—age related macular degeneration	0.000488	0.000488	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—APOE—age related macular degeneration	0.000485	0.000485	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—KDR—age related macular degeneration	0.000481	0.000481	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CCL2—age related macular degeneration	0.000476	0.000476	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—KDR—age related macular degeneration	0.000475	0.000475	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000472	0.000472	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—C3—age related macular degeneration	0.00047	0.00047	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CCL2—age related macular degeneration	0.000466	0.000466	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CCL2—age related macular degeneration	0.000459	0.000459	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—C3—age related macular degeneration	0.000454	0.000454	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—C3—age related macular degeneration	0.000451	0.000451	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—CD36—age related macular degeneration	0.00045	0.00045	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—C3—age related macular degeneration	0.000439	0.000439	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—APOE—age related macular degeneration	0.000438	0.000438	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—C3—age related macular degeneration	0.000432	0.000432	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—KDR—age related macular degeneration	0.000429	0.000429	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—APOE—age related macular degeneration	0.000422	0.000422	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—APOE—age related macular degeneration	0.00042	0.00042	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—KDR—age related macular degeneration	0.000414	0.000414	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CCL2—age related macular degeneration	0.000413	0.000413	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—CD36—age related macular degeneration	0.000412	0.000412	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—KDR—age related macular degeneration	0.000412	0.000412	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—APOE—age related macular degeneration	0.000409	0.000409	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CCL2—age related macular degeneration	0.000407	0.000407	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—APOE—age related macular degeneration	0.000402	0.000402	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—KDR—age related macular degeneration	0.0004	0.0004	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—C3—age related macular degeneration	0.000398	0.000398	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—APOE—age related macular degeneration	0.000397	0.000397	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—KDR—age related macular degeneration	0.000394	0.000394	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—C3—age related macular degeneration	0.000392	0.000392	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—C3—age related macular degeneration	0.000391	0.000391	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—C3—age related macular degeneration	0.000384	0.000384	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—APOE—age related macular degeneration	0.000371	0.000371	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CCL2—age related macular degeneration	0.000368	0.000368	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—APOE—age related macular degeneration	0.000365	0.000365	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—APOE—age related macular degeneration	0.000364	0.000364	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—APOE—age related macular degeneration	0.000364	0.000364	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—KDR—age related macular degeneration	0.000363	0.000363	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—KDR—age related macular degeneration	0.000357	0.000357	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—APOE—age related macular degeneration	0.000357	0.000357	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—KDR—age related macular degeneration	0.000357	0.000357	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—C3—age related macular degeneration	0.000357	0.000357	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CCL2—age related macular degeneration	0.000355	0.000355	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CCL2—age related macular degeneration	0.000353	0.000353	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—KDR—age related macular degeneration	0.00035	0.00035	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CCL2—age related macular degeneration	0.000344	0.000344	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CCL2—age related macular degeneration	0.000338	0.000338	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—APOE—age related macular degeneration	0.000332	0.000332	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—LIPC—age related macular degeneration	0.000331	0.000331	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—KDR—age related macular degeneration	0.000325	0.000325	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CETP—age related macular degeneration	0.000319	0.000319	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CCL2—age related macular degeneration	0.000312	0.000312	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CCL2—age related macular degeneration	0.000307	0.000307	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CCL2—age related macular degeneration	0.000306	0.000306	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—VEGFA—age related macular degeneration	0.000306	0.000306	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CCL2—age related macular degeneration	0.0003	0.0003	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—VEGFA—age related macular degeneration	0.000299	0.000299	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—VEGFA—age related macular degeneration	0.000294	0.000294	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—CD36—age related macular degeneration	0.000293	0.000293	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCL2—age related macular degeneration	0.000279	0.000279	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—VEGFA—age related macular degeneration	0.000265	0.000265	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—VEGFA—age related macular degeneration	0.000262	0.000262	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—APOE—age related macular degeneration	0.000259	0.000259	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—VEGFA—age related macular degeneration	0.000236	0.000236	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—VEGFA—age related macular degeneration	0.000228	0.000228	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—VEGFA—age related macular degeneration	0.000227	0.000227	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—VEGFA—age related macular degeneration	0.000221	0.000221	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—VEGFA—age related macular degeneration	0.000217	0.000217	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—VEGFA—age related macular degeneration	0.0002	0.0002	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—VEGFA—age related macular degeneration	0.000197	0.000197	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—VEGFA—age related macular degeneration	0.000197	0.000197	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—VEGFA—age related macular degeneration	0.000193	0.000193	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CD36—age related macular degeneration	0.000192	0.000192	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—VEGFA—age related macular degeneration	0.000179	0.000179	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—APOE—age related macular degeneration	0.000169	0.000169	CbGpPWpGaD
